Ruthigen Inc. (RTGN) 5.06 $RTGN A Dozen Reasons To Love

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Ruthigen Inc. (RTGN) 5.06 $RTGN

A Dozen Reasons To Love Dermatology Companies
ACCESSWIRE - Tue Jul 14, 8:25AM CDT
WHITEFISH, MT / ACCESSWIRE / July 14, 2015 / There are a number of reasons investors worldwide love dermatology companies. For starters, support of innovation has been key in gaining a far better understanding of skin conditions and advancing effective, safe therapies capable of becoming standards of care. Of course, Wall Street loves upside potential. At a more granular level, the logic underscoring dermatology as a good investment is quite diverse. As David M. Steinberg, Managing Director Equity Research at Jeffries, puts it, dermatology products have several general attributes: 1) shorter development timelines; 2) lower clinical trial costs; 3) perceived lower regulatory hurdles; 4) high cash pay components for aesthetics; 5) a recent track record of success; and 6) a really active M&A market, which Mr. Steinberg described as a second way for shareholders to win. Oculus Innovative Sciences' (NASDAQ: OCLS) CFO Bob Miller and CEO Jim Schutz expanded on Steinberg's view in the company's June earnings call, adding 7) derm has strong pricing, product margins, and insurance coverage; 8) it is a concentrated call point, meaning companies don't need an enormous sales force to cover; 9) derm has fast sales ramps; and 10) dermatology has great valuations or multiples on revenue.
VRX: 21.15 (-1.15), DERM: 33.33 (-0.23), ANAC: 99.06 (-0.14), RTGN: 5.06 (+1.01), OCLS: 4.01 (-0.28), NVS: 83.20 (-0.06)

Oculus Innovative Sciences Announces Sale of 1.65 Million Shares of Ruthigen Stock for $4.5 Million in Non-Dilutive Funding
GlobeNewswire - Tue Jun 16, 5:00AM CDT
-- Ruthigen/Pulmatrix merger closed on June 15, 2015, enabling Oculus' sale of Ruthigen shares to close on or before June 18, 2015
OCLSW: 0.30 (unch), RTGN: 5.06 (+1.01), OCLS: 4.01 (-0.28)

These Biotech Stocks Could Deliver Big Returns for Investors
ACCESSWIRE - Mon Jun 15, 8:35AM CDT
NEW YORK, NY / ACCESSWIRE / June 15, 2015 / This week's events will be focused on the ongoing Greece negotiations with creditors, the largest among them being the IMF, the ECB and Germany. Additionally the FOMC minutes will be released this week pointing investors to clues as to whether the Fed is still patient regarding the proposed first rate hike. Our opinion at UltimateStockAlerts.com has been consistent on this topic for over 3 years now:
IDRA: 1.77 (+0.05), SNSS: 0.67 (+0.02), RTGN: 5.06 (+1.01), XOMA: 0.66 (-0.01)

Oculus Beats Consensus Sales Expectations by 30 Percent, Turnaround Plan Working
ACCESSWIRE - Mon Jun 15, 8:28AM CDT
WHITEFISH, MT / ACCESSWIRE / June 15, 2015 / At the end of May, shares of Oculus Innovative Sciences (NASDAQ: OCLS) broke above their 50 day moving average, a technical resistance at 90 cents and another at $1.05. The move continued to fill a previously open gap at $1.08 and take shares above their 200 day moving average, a sign of bullishness in technical analysis, as the stock printed as high as $1.97 on Tuesday. From the May low of 65 cents, the stock made a bottom-to-top move of 203%. All of this upward movement is important, as the company has received a delisting notice from NASDAQ for deficient bid price. The stock needs to close above $1 for 10 consecutive days in order to satisfy NASDAQ requirements for continued listing. Through June 12, the closing price was above $1 for eight consecutive days.
RTGN: 5.06 (+1.01), OCLS: 4.01 (-0.28)

Ruthigen and Pulmatrix Stockholders Approve Merger
PR Newswire - Fri Jun 12, 3:01PM CDT
Ruthigen, Inc. ("Ruthigen" (NASDAQ: RTGN) and Pulmatrix Inc. ("Pulmatrix" today announced that at Ruthigen's special meeting of stockholders held on June 12, 2015, Ruthigen obtained sufficient votes for each proposal required to consummate the previously announced proposed merger between Ruthigen and Pulmatrix. Pulmatrix previously obtained a sufficient number of written consents from its stockholders to consummate the merger.
RTGN: 5.06 (+1.01)

Panning for Golden Stocks Outside the Gold Industry
ACCESSWIRE - Thu May 28, 4:51PM CDT
WHITEFISH, MT / ACCESSWIRE / May 28, 2015 / Gold miners are their own special breed, utilizing skills most laymen do not understand to analyze the ground, drilling to confirm targets and digging-in to unearth the precious yellow metal. Throughout the world, though, there are still plenty of artisanal miners finding gold and others plucking a nugget from a pan that they stuck in a stream. Whatever the method, it often takes poring through plenty of material and some savvy vision to find the payoff, a tactic that can be applied to many applications in life, including the stock market.
ABT: 45.21 (+0.46), PHG: 26.50 (-0.06), PDCO: 49.52 (+0.16), RTGN: 5.06 (+1.01), OCLS: 4.01 (-0.28), NBY: 2.37 (+0.03)

Antifungals, an Overlooked Biotech Niche With Big Potential
ACCESSWIRE - Wed May 20, 7:37AM CDT
CORAL GABLES, FL / ACCESSWIRE / May 20, 2015 / If a global competition were held for the planet's most sadly ironic places, the hospital would place very high, if not win outright. This is not only true from before the late 19th century when the germ theory of disease became widely accepted. Before then, the hospital - a place that is designed to heal the sick - was just about the best place on Earth to contract a life-threatening infection due to unsanitary surgical procedures. This is still sadly true today as well. Hospitals are still the largest breeding grounds for deadly superbug infections due to the very sanitation procedures meant to stop them.
CDTX: 12.05 (+0.16), RTGN: 5.06 (+1.01)

IPOs & Transactions Week in Review: April 13 - 17 / plus video: M&A expert panel answer 12 questions
PR Newswire - Mon Apr 20, 10:50AM CDT
Vintage, the capital markets, corporate services and institutional & fund services division of PR Newswire, has released its weekly IPO and Transaction summary.
SFBS: 50.50 (-0.13), RTGN: 5.06 (+1.01)

Ruthigen-Pulmatrix Merge, Focus on Respiratory Drugs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 17, 5:33PM CDT
Ruthigen, Inc. (RTGN) and Pulmatrix entered into a definitive merger agreement upon the closing of which Pulmatrix will become a wholly-owned subsidiary of Ruthigen.
CYTK: 11.42 (+0.30), LCI: 31.85 (+0.63), SLXP: 172.96 (+0.15), RTGN: 5.06 (+1.01)

Ruthigen and Pulmatrix Enter into Merger Agreement
PR Newswire - Mon Mar 16, 6:00AM CDT
Ruthigen, Inc. (NASDAQ: RTGN), a biopharmaceutical company ("Ruthigen", and Pulmatrix, Inc., a Lexington, Massachusetts based clinical stage biotechnology company ("Pulmatrix", announced today that on March 13, 2015, they have entered into a definitive merger agreement. Upon the closing of the transactions contemplated by the merger agreement, Pulmatrix will become a wholly-owned subsidiary of Ruthigen and all of Pulmatrix's debt and equity securities outstanding prior to the consummation of the merger will be exchanged for shares of Ruthigen common stock that will represent approximately 81% of the outstanding common stock of Ruthigen. In connection with Pulmatrix's entry into the merger agreement, certain existing institutional investors in Pulmatrix entered into stock purchase agreements with Pulmatrix to invest an additional $10,000,000 in Pulmatrix upon the closing of the merger. Pulmatrix also raised approximately $4,500,000 in February 2015, in contemplation of entering into the merger agreement.
RTGN: 5.06 (+1.01)

Oculus Innovative Sciences sells 350,000 Ruthigen stock at USD2.75 per share in USD962,500 non-dilutive funding
M2 - Mon Mar 16, 4:32AM CDT
Pharmaceutical company Oculus Innovative Sciences (NASDAQ:OCLS) reported on Friday the sale of 350,000 shares of Ruthigen (Nasdaq:RTGN) stock to an undisclosed investor group at USD2.75 per share for non-dilutive funding of USD962,500.
RTGN: 5.06 (+1.01), OCLS: 4.01 (-0.28)

Oculus Innovative Sciences Announces Sale of 350,000 Shares of Ruthigen Stock for $962,500 in Non-Dilutive Funding
GlobeNewswire - Mon Mar 16, 2:05AM CDT
-- Additional $4.5 million in non-dilutive funding in sale of remaining 1.65 million Ruthigen shares upon closing of Ruthigen/Pulmatrix merger expected by no later than August 2015
RTGN: 5.06 (+1.01), OCLS: 4.01 (-0.28)

Oculus Innovative Sciences Reports Financial Results for the Third Quarter of Fiscal Year 2015
GlobeNewswire - Thu Feb 12, 3:09PM CST
-- Total revenue of $3.2 million for the third quarter
RTGN: 5.06 (+1.01), OCLS: 4.01 (-0.28)

Oculus Innovative Sciences to divest Ruthigen shares for USD5.5m in event of Ruthigen merger
M2 - Mon Jan 12, 6:53AM CST
Pharmaceutical company Oculus Innovative Sciences (NasdaqCM:OCLS) reported on Monday the launch of a securities purchase agreement with two current Ruthigen investors.
RTGN: 5.06 (+1.01), OCLS: 4.01 (-0.28)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Orangetheory Adds NASM Training for Coaching Edge

Updated Category News Views 19

A Shift in Coaching Standards Ever seen a fitness brand tilt towards a change so fast it leaves you slack-jawed? Well, here we go with Orangetheory Fitness pushing its chips all in with NASM-certified coaches geared for the GLP-1 era. A bold move? Sure, but they aim to become trendsetters instead of just another player in the fitness game. The Impact of NASM Certification...

Continue Reading
Stark Future Amasses €150M, Revving Up Electric Bike Dominance

Updated Category News Views 74

Well, if you've been keeping your eye on electric vehicles, this is a story that might raise those eyebrows. Stark Future, a name perhaps not buzzing on every street just yet, has gone and done it—snagged over €150 million in fresh capital. Breaking Barriers with Record-breaking Numbers Stark Future didn't just make a ripple; they caused a tsunami. This buzzing...

Continue Reading
Atomera Preps for Key Craig-Hallum Conference

Updated Category News Views 13

Unpacking the NYC Gathering Alight, let's comb through the moving parts here. Atomera Inc., ticker NASDAQ: ATOM for those eyeing the dance of numbers, is all set to step into the limelight at the 17th Annual Craig-Hallum Alpha Select Conference on November 17, 2026. This shindig isn't just another date on the calendar; it's a strategic haunt where Atomera will rub...

Continue Reading
Sovereign Crown Vault's Auction Draws Numismatic Collectors

Updated Category News Views 11

A Legendary Auction with Three Generations of Passion Coins, eh? They might just be small metallic disks to the untrained eye, but these suckers tell stories that stretch beyond any bank ledger. Sovereign Crown Vault LLC knows this, and they’re gearing up for quite the show on November 22, 2026. Their Holiday Season Kickoff Spectacular is about to lure in collectors...

Continue Reading
Halfday Iced Tea Shakes Up U.S. Retail Scene

Updated Category News Views 6

Halfday's Meteoric Rise in the U.S. Market Sometimes, you pick up a can of iced tea, and it just changes the game. That’s exactly what Halfday is doing, stepping on the accelerator and leaving traditional iced tea brands in the dust. With their latest announcement, they've snagged the title of the fastest-growing modern tea brand in U.S. multi-outlet retail. It's the...

Continue Reading
AI Pushes Asset Managers Towards New Investment Growth

Updated Category News Views 5

AI: A Double-Edged Sword for Asset Managers Peeled straight from the heart of New York's financial buzz, AI is changing the game for asset and wealth managers. Now, we ain’t talking about some futuristic sci-fi scene, but real-world shifts that are scratching their way into boardrooms. Nearly 80% of firms playing the AI card see a sweet lift in productivity and...

Continue Reading
HLTH USA 2026 Spotlights AI and Health Innovation

Updated Category News Views 12

The Pulse of Innovation at HLTH USA 2026 Diving headfirst into the heart of healthcare innovation, HLTH USA 2026 kicked off with gusto in Las Vegas. Discussions are swirling around AI advancements and the next generation of payer-provider collaboration. Who knew healthcare could be this thrilling? The event is already shaping up to be a powerhouse of change, buzzing with...

Continue Reading
Clinch Scores Big with Two Prestigious Industry Honors

Updated Category News Views 14

Clinch's Dual Triumph in Advertising Innovation No one throws a ticker symbol over their cereal for recognizing brilliance, but when an outfit like Clinch gets double applause at the big dance, even we old-timers have to tip our hats. On November 16, 2026, the advertising world saw some fireworks. Clinch took home not one but two hefty awards—the kind that say you've...

Continue Reading
Parallels Desktop Tops 2026 Picks for Windows on Mac

Updated Category News Views 28

Diving into the Cross-Platform Conundrum Now, I've been in the trenches long enough to know that when companies start relying on Mac computers but can't ditch their essential Windows apps, they're bound to hit a digital brick wall. Picture this—accounting, enterprise management, all that jazz that still needs Windows to function. For those jumping between these two...

Continue Reading
ZTE Reinvents Energy for AI Data Centers

Updated Category News Views 64

The Great Race: Power and AI in Sync Here we are, neck-deep in the AI era, where the demand for raw computing power just won’t quit. With every data-hungry application and supercharged algorithm, companies are scrambling to keep up. But there’s a nasty little dragon in this fairy tale—energy efficiency. ZTE isn’t just acknowledging this beast; they’re ready to...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrating 40 Years: The Evolution of Fudan SoM

Updated Category News Views 275

Fudan SoM Celebrates a Milestone in Business Education The Fudan University School of Management recently celebrated its 40th anniversary with great enthusiasm, showcasing a commitment to fostering global business education. This significant event coincided with the launch of the 2025 Global Business Education Deans' Forum and Expo, a pivotal gathering that highlights...

Continue Reading
ICU Medical Stock Hits Record Low: What Investors Should Know

Updated Category News Views 321

ICU Medical Faces Significant Market Challenges Amidst a turbulent market landscape, ICU Medical (NASDAQ: ICUI) has witnessed its stock price decline to a 52-week low of $1.69, resulting in a market capitalization plummeting to approximately $7.65 million. The company’s substantial dip in value, which is around -86.22% over the past year, highlights a significant...

Continue Reading
Sagimet Biosciences Unveils Comprehensive Financial Results and Milestones

Updated Category News Views 178

Sagimet Biosciences Shares 2024 Financial Highlights Sagimet Biosciences Inc. (NASDAQ: SGMT), a prominent clinical-stage biopharmaceutical firm focusing on innovative therapies for metabolic and fibrotic disorders, recently revealed its financial outcomes for the full year ended December 31, 2024. With notable advancements in their drug pipeline, Sagimet is...

Continue Reading
Exploring the Expanding Opportunities in Cannabidiol Market

Updated Category News Views 158

Cannabidiol Market Growth Projections The global cannabidiol (CBD) market is a rapidly evolving sector that is transforming the healthcare landscape. With increasing recognition of its therapeutic potential, the market was valued at approximately USD 8.97 billion in 2024 and is set to reach an impressive USD 38.97 billion by 2034. This remarkable growth, projected at a...

Continue Reading
Kelley Morris Appointed President of Hospital Foundations

Updated Category News Views 476

Kelley Morris Steps into Leadership Role The Memorial and Joe DiMaggio Children's Hospital Foundations have made a significant change in leadership by appointing Kelley Morris, MHA, as President and CEO. With an impressive background spanning over 25 years in healthcare philanthropy, operations, and research administration, Morris is set to lead the Foundations in...

Continue Reading